German Helmet Radiation Therapy Indication

Primary Indication: Scalp Basal Cell Carcinoma

The National Comprehensive Cancer Network recommends German Helmet radiation therapy for patients with scalp basal cell carcinomas who are not surgical candidates or prefer non-surgical treatment, particularly those over 60 years of age 1, 2
The American College of Radiology suggests considering German Helmet RT for patients with scalp BCCs who have medical comorbidities precluding surgical intervention, or cosmetic considerations, particularly for extensive scalp involvement where surgical reconstruction would be challenging 1, 3

The National Comprehensive Cancer Network reports that radiation therapy for primary basal cell carcinoma demonstrates 5-year local control rates of 93-96%, though this is inferior to surgical approaches, with a recurrence rate of 7.5% vs 0.7% for surgery 1
The American Society for Radiation Oncology notes that German Helmet RT is most effective for primary (vs recurrent) BCCs, smaller diameter lesions, and nodular histologic subtype (vs other aggressive subtypes) 1

The National Comprehensive Cancer Network advises against using German Helmet RT in patients with genetic syndromes predisposing to skin cancer, such as basal cell nevus syndrome (Gorlin syndrome), xeroderma pigmentosum, connective tissue diseases, such as lupus, scleroderma, or prior radiation to the same field 1, 2, 3

The American Association of Physicists in Medicine recommends proper medical physics support to ensure adequate surface dose to the target area, with total doses typically 45-53 Gy and appropriate fractionation 1, 3

The National Comprehensive Cancer Network suggests that German Helmet RT may be indicated postoperatively for high-risk scalp BCCs with substantial perineural involvement or positive margins after Mohs micrographic surgery or complete circumferential peripheral and deep margin assessment (CCPDMA) 1, 2

The American Society for Radiation Oncology notes that critical caveats to avoid include the higher recurrence rate compared to surgery, poorer cosmetic outcomes, and more postoperative complications, as well as the importance of long-term follow-up since 56% of recurrences in primary BCC occur >5 years after treatment 1, 2